Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: A comparison

Cancer

Volumn 99, Issue 3, 2003, Pages 135-140

  Chacho, Mary S ^a   Mattie, Mark E ^a   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical carcinoma; Liquid based cytology; Papanicolaou (Pap) smear; ThinPrep

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTODIAGNOSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FEMALE; FOOD AND DRUG ADMINISTRATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0038119751     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11102     Document Type: Article

References (18)

1. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989;261:737-743.
2. Linder J, Zahniser D. The ThinPrep® Pap test. A review of clinical studies. Acta Cytol. 1997;41:30-38.
3. Papillo JL, Zarka M, St. John TL. Evaluation of the Thin- Prep® Pap test in clinical practice. Acta Cytol. 1998;42:203-208.
4. Guidos BJ, Selvaggi SM. Use of the ThinPrep® Pap test. Diagn Cytopathol. 1999;20:70-73.
5. Laverty CR, Roberts J, Gurley M, et al. ThinPrep® as an adjunct test in routine cervical cytology: comparison with the conventional smear [abstract]. Acta Cytol. 1997;41:1578.
6. Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep® cervical cancer screening system. Acta Cytol. 1998;42:209-213.
7. Kurman RJ, Solomon D. The Bethesda System for reporting cervical/vaginal cyotologic diagnoses; definitions, criteria, and explanatory notes for terminology and specimen adequacy. New York: Springer-Verlag, 1994.
8. Papillo JL, St. John TL, Mahoney PD, Sanville RS. Reprocessing of unsatisfactory Thin-Prep® samples: procedures to improve specimen adequacy and increase detection of cervical abnormalities [abstract]. Acta Cytol. 1998;42:1246.
9. Hellman DJ, Bolick DR. Improving the adequacy of the ThinPrep® Papanicolaou test. Acta Cytol. 1998;42:1241.
10. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001;83:439-444.
11. Clark SB, Dawson AE. Invasive squamous cell carcinoma in ThinPrep® specimens: diagnostic clues in the cellular pattern. Diagn Cytopathol. 2002;26:1-4.
12. Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based Study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer (Cancer Cytopathol). 1999;87:48-55.
13. Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer. 1995;71:894-897.
14. Boddington MM, Spriggs AI, Cowdrell RH. Adenocarcinoma of the uterine cervix: cytological evidence of a long preclinical evolution. Br J Obstet Gynaecol. 1976;83:900-903.
15. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81:159-166.
16. Brinton, LA, Tashima KT, Lehman HF, et al. Epidemiology of cervical cancer by cell type. Cancer Res. 1987;47:1706-1711.
17. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F. Thin- Prep® Pap Test. Accuracy for glandular disease. Acta Cytol. 1999;43:81-85.
18. Bai H, Sung J, Steinhoff MM. ThinPrep® Pap test promotes detection of glandular lesions of the endocervix. Diagn Cytopathol. 2000;23:19-22.